Navigating the current landscape of clinical genetic testing for inherited retinal dystrophies
- PMID: 25790163
- DOI: 10.1038/gim.2015.15
Navigating the current landscape of clinical genetic testing for inherited retinal dystrophies
Abstract
Inherited eye disorders are a significant cause of vision loss. Genetic testing can be particularly helpful for patients with inherited retinal dystrophies because of genetic heterogeneity and overlapping phenotypes. The need to identify a molecular diagnosis for retinal dystrophies is particularly important in the era of developing novel gene therapy-based treatments, such as the RPE65 gene-based clinical trials and others on the horizon, as well as recent advances in reproductive options. The introduction of massively parallel sequencing technologies has significantly advanced the identification of novel gene candidates and has expanded the landscape of genetic testing. In a relatively short time clinical medicine has progressed from limited testing options to a plethora of choices ranging from single-gene testing to whole-exome sequencing. This article outlines currently available genetic testing and factors to consider when selecting appropriate testing for patients with inherited retinal dystrophies.
Similar articles
-
RPE65-Associated Retinal Dystrophies: Phenotypes and Treatment Effects with Voretigene Neparvovec.Klin Monbl Augenheilkd. 2024 Mar;241(3):259-265. doi: 10.1055/a-2227-3671. Epub 2024 Mar 20. Klin Monbl Augenheilkd. 2024. PMID: 38508214 Review. English.
-
[RPE65-retinal Dystrophies: From the Spectrum of the Clinical Picture to Gene Therapy].Klin Monbl Augenheilkd. 2024 Mar;241(3):257-258. doi: 10.1055/a-2237-7300. Epub 2024 Mar 20. Klin Monbl Augenheilkd. 2024. PMID: 38508213 German. No abstract available.
-
The new landscape of retinal gene therapy.Am J Med Genet C Semin Med Genet. 2020 Sep;184(3):846-859. doi: 10.1002/ajmg.c.31842. Epub 2020 Sep 5. Am J Med Genet C Semin Med Genet. 2020. PMID: 32888388 Review.
-
Voretigene neparvovec-rzyl (Luxturna) for inherited retinal dystrophy.Med Lett Drugs Ther. 2018 Mar 26;60(1543):53-55. Med Lett Drugs Ther. 2018. PMID: 29635265 No abstract available.
-
Dog models for blinding inherited retinal dystrophies.Hum Gene Ther Clin Dev. 2015 Mar;26(1):15-26. doi: 10.1089/humc.2014.155. Epub 2015 Feb 11. Hum Gene Ther Clin Dev. 2015. PMID: 25671556 Free PMC article. Review.
Cited by
-
Screening copy number variations in 35 unsolved inherited retinal disease families.Hum Genet. 2024 Feb;143(2):197-210. doi: 10.1007/s00439-023-02631-4. Epub 2024 Jan 29. Hum Genet. 2024. PMID: 38282009 Free PMC article.
-
Investigation of Structural Alterations in Inherited Retinal Diseases: A Quantitative SD-OCT-Analysis of Retinal Layer Thicknesses in Light of Underlying Genetic Mutations.Int J Mol Sci. 2022 Dec 16;23(24):16007. doi: 10.3390/ijms232416007. Int J Mol Sci. 2022. PMID: 36555650 Free PMC article.
-
Patient-Reported Health-Related Quality of Life in Individuals with Inherited Retinal Diseases.Ophthalmol Sci. 2021 Dec 23;2(1):100106. doi: 10.1016/j.xops.2021.100106. eCollection 2022 Mar. Ophthalmol Sci. 2021. PMID: 36246188 Free PMC article.
-
Utility of No-Charge Panel Genetic Testing for Inherited Retinal Diseases in a Real-World Clinical Setting.J Vitreoretin Dis. 2022 Sep-Oct;6(5):351-357. doi: 10.1177/24741264221100936. Epub 2022 Aug 25. J Vitreoretin Dis. 2022. PMID: 36213299 Free PMC article.
-
Advancing precision medicines for ocular disorders: Diagnostic genomics to tailored therapies.Front Med (Lausanne). 2022 Jul 15;9:906482. doi: 10.3389/fmed.2022.906482. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35911417 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical